Skip to main content
. Author manuscript; available in PMC: 2016 Sep 24.
Published in final edited form as: J Med Chem. 2015 Sep 10;58(18):7485–7500. doi: 10.1021/acs.jmedchem.5b01005

Table 3.

DMPK Profiling of Early Analogues

graphic file with name nihms-766653-f0011.jpg
no. cLogPa LLEb mGlu3 IC50 (nM) fold vs mGlu5 rat plasma Fuc CLplasma (mL/min/kg)d VSS (L/kg)d
24 3.96 2.38 462 0.20 0.060 95 40 3.5
38 4.24 1.70 1160 >25 0.005 32 82 2.2
47 3.06 3.21 539 >18 0.135 88 82 6.6
48 3.57 2.65 605 4.8 0.034 141 29 5.2
a

Calculated using Dotmatics Elemental (www.dotmatics.com/products/elemental/).

b

LLE (ligand-lipophilicity efficiency) = pIC50 – cLogP.

c

Fu = fraction unbound.

d

Rat IV PK results (n = 2); dose = 0.2 mg/kg; solution in 9% EtOH, 37% PEG 400, 54% DMSO (2 mg/mL).

HHS Vulnerability Disclosure